Skip to content
Disclosery

13F-HR/A filed by HBK INVESTMENTS L P

HBK INVESTMENTS L P filed this 13F-HR/A for the quarter ended 2021-12-31, filed 2023-02-14, with 9 holding rows worth $1,044,098,961.

Accession
0001011443-23-000005
Filer
CIK 1011443
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, amendment of type new holdings, 9 entries on the cover page, a total value of $1,044,098,961 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,044,098,961 with VALUE read as dollars as filed, 13F file number 028-06078. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CYRUSONE INC23283R100COM3,150,000$282,618,000dollars as filed
ATHENE HOLDING LTDG0684D107CL A2,743,465$228,316,919dollars as filed
CERNER CORP156782104COM2,130,000$197,813,100dollars as filed
VONAGE HLDGS CORP92886T201COM6,046,844$125,713,887dollars as filed
ARENA PHARMACEUTICALS INC040047607COM NEW761,800$70,801,692dollars as filed
WELBILT INC949090104COM2,400,000$57,048,000dollars as filed
ROGERS CORP COM775133101Stock163,181$44,548,413dollars as filed
VONAGE HLDGS CORP92886TAJ1NOTE 1.750% 6/025,000,000$33,388,750dollars as filedprincipal
ORTHO CLINICAL DIAGNOSTICS HG6829J107ORD SHS180,000$3,850,200dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001011443-22-000002 base2022-02-14acceptance time not in the bulk data set
13F-HR/A 0001011443-23-000005this filing2023-02-14acceptance time not in the bulk data set
13F-HR/A 0001011443-24-000017 added2024-05-15acceptance time not in the bulk data set